Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

41.7%

5 terminated/withdrawn out of 12 trials

Success Rate

54.5%

-32.0% vs industry average

Late-Stage Pipeline

33%

4 trials in Phase 3/4

Results Transparency

33%

2 of 6 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A
5(50.0%)
Phase 4
3(30.0%)
Phase 2
1(10.0%)
Phase 3
1(10.0%)
10Total
N/A(5)
Phase 4(3)
Phase 2(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)